PRO (“The Window Is Open”): In patients with cirrhosis with prior variceal hemorrhage and ascites, the clinical benefits of nonselective beta‐blockers outweigh the risks and should be prescribed
Watch a video presentation of this article
Gespeichert in:
Veröffentlicht in: | Clinical liver disease (Malden, Mass.) Mass.), 2018-05, Vol.11 (5), p.119-122 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 122 |
---|---|
container_issue | 5 |
container_start_page | 119 |
container_title | Clinical liver disease (Malden, Mass.) |
container_volume | 11 |
creator | Tholey, Danielle Roth, Nitzan Schiano, Thomas |
description | Watch a video presentation of this article |
doi_str_mv | 10.1002/cld.700 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6385954</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2050513088</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3100-d3fd557a8a0dfbb0ecf1d3417012fc0e09feb906b696026fb6407e371ffc236a3</originalsourceid><addsrcrecordid>eNp1kltuEzEUhkcIRKtSsQNkiQeKIOXMfYYHJBRukSIFoSIeLY_nOOPWsVN7JlHfsgQWAPthHVkJp02oChJ-8eX__Pv414mixzGcxgDJK2na0xLgXnSYQFaMkqzK7t9ZH0THIZwDjSou6fBhdJBCXScVxIfRr89fZuxku_lx1iH7pm3r1mwS2GyJdrv5-fw1m1i2FL1G2we21n3HpPa-c0Hvt0uvnWcr4bVEYViHC0e6mCMTtmUiSN1jeMl6spdGWy0JatCi0mToFLPOBjQoe71CEnqx3XxvjJMX6Ekf-jXqeXdz3etwEW5cQ-cG0xJNr2OQXjfYPooeKGECHu_no-jrh_dn40-j6ezjZPx2OpIphTVqU9XmeSkqAa1qGkCp4jbNKJg4URIQaoVNDUVT1AUkhWqKDEpMy1gpmaSFSI-iNzvf5dAssJUUjBeGUwwL4a-4E5r_rVjd8blb8SKt8jrPyOBkb-Dd5YCh5wsdJBojLLoh8CSJoS6ytKgJffoPeu4Gb-l7PIEc8jiFqiLq2Y6S3oXgUd0WEwO_bhBODcKpQYh8crf2W-5POxDwYgestcGr__nw8fTdtd1vPZXKoQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2050513088</pqid></control><display><type>article</type><title>PRO (“The Window Is Open”): In patients with cirrhosis with prior variceal hemorrhage and ascites, the clinical benefits of nonselective beta‐blockers outweigh the risks and should be prescribed</title><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Tholey, Danielle ; Roth, Nitzan ; Schiano, Thomas</creator><creatorcontrib>Tholey, Danielle ; Roth, Nitzan ; Schiano, Thomas</creatorcontrib><description>Watch a video presentation of this article</description><identifier>ISSN: 2046-2484</identifier><identifier>EISSN: 2046-2484</identifier><identifier>DOI: 10.1002/cld.700</identifier><identifier>PMID: 30992801</identifier><language>eng</language><publisher>United States: Wiley Subscription Services, Inc</publisher><subject>Beta blockers ; Clinical outcomes ; Hemorrhage ; Liver cirrhosis ; Liver diseases ; Review ; Reviews</subject><ispartof>Clinical liver disease (Malden, Mass.), 2018-05, Vol.11 (5), p.119-122</ispartof><rights>2018 by the American Association for the Study of Liver Diseases</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c3100-d3fd557a8a0dfbb0ecf1d3417012fc0e09feb906b696026fb6407e371ffc236a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6385954/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6385954/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30992801$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tholey, Danielle</creatorcontrib><creatorcontrib>Roth, Nitzan</creatorcontrib><creatorcontrib>Schiano, Thomas</creatorcontrib><title>PRO (“The Window Is Open”): In patients with cirrhosis with prior variceal hemorrhage and ascites, the clinical benefits of nonselective beta‐blockers outweigh the risks and should be prescribed</title><title>Clinical liver disease (Malden, Mass.)</title><addtitle>Clin Liver Dis (Hoboken)</addtitle><description>Watch a video presentation of this article</description><subject>Beta blockers</subject><subject>Clinical outcomes</subject><subject>Hemorrhage</subject><subject>Liver cirrhosis</subject><subject>Liver diseases</subject><subject>Review</subject><subject>Reviews</subject><issn>2046-2484</issn><issn>2046-2484</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNp1kltuEzEUhkcIRKtSsQNkiQeKIOXMfYYHJBRukSIFoSIeLY_nOOPWsVN7JlHfsgQWAPthHVkJp02oChJ-8eX__Pv414mixzGcxgDJK2na0xLgXnSYQFaMkqzK7t9ZH0THIZwDjSou6fBhdJBCXScVxIfRr89fZuxku_lx1iH7pm3r1mwS2GyJdrv5-fw1m1i2FL1G2we21n3HpPa-c0Hvt0uvnWcr4bVEYViHC0e6mCMTtmUiSN1jeMl6spdGWy0JatCi0mToFLPOBjQoe71CEnqx3XxvjJMX6Ekf-jXqeXdz3etwEW5cQ-cG0xJNr2OQXjfYPooeKGECHu_no-jrh_dn40-j6ezjZPx2OpIphTVqU9XmeSkqAa1qGkCp4jbNKJg4URIQaoVNDUVT1AUkhWqKDEpMy1gpmaSFSI-iNzvf5dAssJUUjBeGUwwL4a-4E5r_rVjd8blb8SKt8jrPyOBkb-Dd5YCh5wsdJBojLLoh8CSJoS6ytKgJffoPeu4Gb-l7PIEc8jiFqiLq2Y6S3oXgUd0WEwO_bhBODcKpQYh8crf2W-5POxDwYgestcGr__nw8fTdtd1vPZXKoQ</recordid><startdate>201805</startdate><enddate>201805</enddate><creator>Tholey, Danielle</creator><creator>Roth, Nitzan</creator><creator>Schiano, Thomas</creator><general>Wiley Subscription Services, Inc</general><general>John Wiley and Sons Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>201805</creationdate><title>PRO (“The Window Is Open”): In patients with cirrhosis with prior variceal hemorrhage and ascites, the clinical benefits of nonselective beta‐blockers outweigh the risks and should be prescribed</title><author>Tholey, Danielle ; Roth, Nitzan ; Schiano, Thomas</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3100-d3fd557a8a0dfbb0ecf1d3417012fc0e09feb906b696026fb6407e371ffc236a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Beta blockers</topic><topic>Clinical outcomes</topic><topic>Hemorrhage</topic><topic>Liver cirrhosis</topic><topic>Liver diseases</topic><topic>Review</topic><topic>Reviews</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tholey, Danielle</creatorcontrib><creatorcontrib>Roth, Nitzan</creatorcontrib><creatorcontrib>Schiano, Thomas</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Clinical liver disease (Malden, Mass.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tholey, Danielle</au><au>Roth, Nitzan</au><au>Schiano, Thomas</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>PRO (“The Window Is Open”): In patients with cirrhosis with prior variceal hemorrhage and ascites, the clinical benefits of nonselective beta‐blockers outweigh the risks and should be prescribed</atitle><jtitle>Clinical liver disease (Malden, Mass.)</jtitle><addtitle>Clin Liver Dis (Hoboken)</addtitle><date>2018-05</date><risdate>2018</risdate><volume>11</volume><issue>5</issue><spage>119</spage><epage>122</epage><pages>119-122</pages><issn>2046-2484</issn><eissn>2046-2484</eissn><abstract>Watch a video presentation of this article</abstract><cop>United States</cop><pub>Wiley Subscription Services, Inc</pub><pmid>30992801</pmid><doi>10.1002/cld.700</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2046-2484 |
ispartof | Clinical liver disease (Malden, Mass.), 2018-05, Vol.11 (5), p.119-122 |
issn | 2046-2484 2046-2484 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6385954 |
source | EZB-FREE-00999 freely available EZB journals; PubMed Central |
subjects | Beta blockers Clinical outcomes Hemorrhage Liver cirrhosis Liver diseases Review Reviews |
title | PRO (“The Window Is Open”): In patients with cirrhosis with prior variceal hemorrhage and ascites, the clinical benefits of nonselective beta‐blockers outweigh the risks and should be prescribed |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T13%3A44%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=PRO%20(%E2%80%9CThe%20Window%20Is%20Open%E2%80%9D):%20In%20patients%20with%20cirrhosis%20with%20prior%20variceal%20hemorrhage%20and%20ascites,%20the%20clinical%20benefits%20of%20nonselective%20beta%E2%80%90blockers%20outweigh%20the%20risks%20and%20should%20be%20prescribed&rft.jtitle=Clinical%20liver%20disease%20(Malden,%20Mass.)&rft.au=Tholey,%20Danielle&rft.date=2018-05&rft.volume=11&rft.issue=5&rft.spage=119&rft.epage=122&rft.pages=119-122&rft.issn=2046-2484&rft.eissn=2046-2484&rft_id=info:doi/10.1002/cld.700&rft_dat=%3Cproquest_pubme%3E2050513088%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2050513088&rft_id=info:pmid/30992801&rfr_iscdi=true |